Finding Common Ground Federal Circuit Clarifies Ipr Estoppel
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Written by:Nathan D. Reeves and Sarah Haj-Maharsi
INGENICO INC. v. IOENGINE, LLC
Before Dyk, Prost, and Hughes. Appeal from the United States District Court for the District of Delaware.
Summary: IPR estoppel does not preclude reliance on public-use evidence that is substantively identical to printed publications that could have been raised in the IPR.
Ingenico filed a declaratory judgment action against IOENGINE, alleging invalidity. Before trial, Ingenico also filed IPR petitions challenging the validity of IOENGINE’s patents, which led to final written decisions. At trial, Ingenico introduced evidence of prior art systems, alleging invalidity based on public use. The jury found the claims invalid as anticipated and obvious.
On appeal, IOENGINE argued Ingenico should have been estopped from introducing its public-use evidence. IOENGINE argued that Ingenico’s prior art systems were cumulative of substantively identical printed publications that reasonably could have been raised in IPR, including the system’s Readme instruction document. The Federal Circuit disagreed. The court noted that IPR estoppel prohibits a petitioner from asserting grounds that were raised or reasonably could have been raised in an IPR. The Federal Circuit held that “grounds” in this context refers to theories of invalidity rather than the prior art itself. Because theories of invalidity based in part on a public use cannot be raised in an IPR, they are not subject to estoppel in district court. Accordingly, the Federal Circuit affirmed the district court’s decision.
Editor: Sean Murray
More insights
Fresh From the Bench: Latest Precedential Patent Case
Ridge Corp. et al. v. Kirk NationaLease Co. et al. , Appeal No. 2025-1254 (Fed. Cir. July 13, 2026) In its only precedential patent opinion last week, the Federal Circuit considered an appeal of a preliminary injunction issued by the U.S. District Court…
Fresh From the Bench: Latest Precedential Patent Cases
CASE OF THE WEEK Wyeth LLC v. AstraZeneca Pharmaceuticals LP , Appeal No. 2024-2325 (Fed. Cir. July 9, 2026) In our Case of the Week, the Federal Circuit affirmed a district court ruling reversing a $107.5 million jury verdict against AstraZeneca in a case…
Enanta Pharmaceuticals, Inc. v. Pfizer Inc., Appeal No. 2025-1427 (Fed. Cir. Jun. 23, 2026)
CASE OF THE WEEK Enanta Pharmaceuticals, Inc. v. Pfizer Inc., Appeal No. 2025-1427 (Fed. Cir. Jun. 23, 2026) In our Case of the Week, the Federal Circuit affirmed summary judgment invalidating all claims of Enanta’s Patent No. 11,358,953 as…